Form 4: Allison Transmission Executive Teresa van Niekerk Reports Stock Transactions
SEC Form 4
Teresa van Niekerk, VP and Chief Procurement Officer of Allison Transmission Holdings, reports multiple transactions involving common stock and derivative securities, including the settlement of restricted stock units and stock options.
Summary
- Teresa van Niekerk, VP, Chief Procurement Officer of Allison Transmission Holdings, filed a Form 4 detailing changes in beneficial ownership.
- On February 23, 2024, van Niekerk settled 1,101 restricted stock units (RSUs) and 42 dividend equivalent rights (DERs), receiving common stock.
- Also on February 23, 2024, 324 shares were withheld to cover tax obligations related to the vesting of DERs and RSUs.
- On February 26, 2024, van Niekerk exercised stock options to acquire 2,761 shares at $43.13, 3,302 shares at $39.42 and 2,886 shares at $47.35.
- On February 26, 2024, van Niekerk sold 6,241 shares at a weighted average price of $74.8718, with prices ranging from $74.7488 to $74.9799.
- Following these transactions, van Niekerk directly owns 21,112 shares of Allison Transmission Holdings Inc. common stock.
Sentiment
Score: 5
Explanation: This is a routine filing of stock transactions. It doesn't indicate overwhelmingly positive or negative sentiment, but rather normal executive compensation activity.
Industry Context
Executive stock transactions are a normal part of corporate governance and provide insight into an insider's perspective on the company's value. Monitoring these transactions can be useful for investors.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- Form 4 filings are standard practice for reporting changes in beneficial ownership as required by the SEC.
- The vesting schedules and exercise prices of the stock options are typical for executive compensation plans.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
- The transactions reflect part of the executive's compensation and incentive structure.
Key Dates
| Date | Description |
|---|---|
| 02/10/2022 | First vesting date of employee stock option (2,761 shares) in three equal annual installments. |
| 02/23/2022 | Date of grant for restricted stock units (RSUs) settled on 02/23/2024. |
| 02/23/2023 | First vesting date of employee stock option (3,302 shares) in three equal annual installments. |
| 02/22/2024 | First vesting date of employee stock option (2,886 shares) in three equal annual installments. |
| 02/23/2024 | Settlement of restricted stock units (RSUs) and dividend equivalent rights (DERs). |
| 02/26/2024 | Exercise of stock options and sale of common stock. |
| 02/27/2024 | Date of Form 4 signature. |
| 02/10/2031 | Expiration date of employee stock option (2,761 shares). |
| 02/23/2032 | Expiration date of employee stock option (3,302 shares). |
| 02/22/2033 | Expiration date of employee stock option (2,886 shares). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.